+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Intelligence In Cancer Diagnostics Market Size, Share & Trends Analysis Report By Component, By Cancer Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 90 Pages
  • July 2023
  • Region: Global
  • Grand View Research
  • ID: 5681741
Description Jump to:

The global AI in cancer diagnostics market size is expected to reach USD 996.1 million by 2030, growing at 26.3% CAGR from 2023 to 2030. The increasing need for lowering healthcare costs, the rising importance of big data in healthcare, improving adoption of precision medicine, and declining hardware costs are key factors driving the growth.



The increasing scope of applications of artificial intelligence (AI) in various healthcare fields, including diagnostics; the rising prevalence of cancer; and the growing shortage of public health workforce are some of the key factors anticipated to fuel the adoption of artificial intelligence (AI) in cancer diagnostics over the forecast period. In addition, the increasing applicability of AI-based tools in cancer care and the rise in venture capital investments is further driving the surge in demand for this technology.

The presence of prominent players in the market such as Microsoft, Flatiron, Therapixel, and Tempus, is anticipated to positively impact the growth. These players are adopting strategies such as acquisitions, collaborations, expansions, and new product launches to increase the reach of their products in the industry and increase the availability of their products & services in diverse geographical areas. For instance, in December 2021, Microsoft announced a partnership with CVS Health to develop innovative solutions for patients to improve their health while empowering healthcare professionals with tools to better service patients.

Furthermore, the rising government support in the form of funding and initiatives for the development of healthcare infrastructure is anticipated to drive the demand for technologically advanced and cost-efficient devices over the forecast period.

AI In Cancer Diagnostics Market Report Highlights

  • Based on component, the software solutions segment held the largest market share of 43.7% in 2022. The development of AI-based software solutions for cancer diagnostics is one of the key factors boosting segment growth
  • Based on cancer type, the other cancers segment emerged as the largest segment with a revenue share of 33.6% in 2022. Growing adoption of a sedentary lifestyle increased alcohol & tobacco consumption, and physical inactivity are driving the incidence of cancers such as bladder and skin cancers
  • Based on end-user, the hospital segment emerged as the largest end-user in the market, with a market share of 57.7% in 2022. The growing shortage of medical professionals and technological advancements in hospitals is expected to drive the segment
  • North America dominated the global market with a share of 56.0% in 2022. The rising adoption of healthcare IT solutions, the well-established healthcare sector, and the availability of funding for developing AI capabilities are some of the factors contributing to the growth of the market in the region

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.2 Research Methodology
1.2.1 Information Procurement
1.2.1.1 Purchased Database:
1.2.1.2 The Internal Database
1.2.2 Primary Research:
1.3 Research Scope And Assumptions
1.4 Research Methodology (Parent Market Approach And Commodity Flow Analysis)
1.4.1 Research Methodology Steps: Commodity Flow Approach
1.5 List Of Secondary Sources
1.6 List Of Primary Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Regional Insight
2.4 Competitive Insights
2.5 Artificial Intelligence (Ai) In Cancer Diagnostics Market Snapshot
2.6 Artificial Intelligence (Ai) In Cancer Diagnostics Segment Snapshot
2.7 Artificial Intelligence (Ai) In Cancer Diagnostics Competitive Snapshot
Chapter 3 Artificial Intelligence (Ai) In Cancer Diagnostics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.1.1 Ai In Healthcare Market
3.1.2 Related/Ancillary Market Outlook
3.1.2.1 Artificial Intelligence In Medical Imaging Market
3.2 Penetration And Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 Artificial Intelligence (Ai) In Cancer Diagnostics Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Early Detection And Classification Of Diseases
3.4.1.2 Early Detection And Classification Of Cancer
3.4.1.3 Increasing Use Of Ai In Chronic Disease Management
3.4.1.4 Increasing Number Of Startups & Collaborations And Growing Venture Capitalist Funding
3.4.2 Market Restraint Analysis
3.4.2.1 Highly Regulated Industry
3.4.2.2 Procurement Costs And Maintenance
3.5 Artificial Intelligence In Cancer Diagnostics Market Analysis Tools
3.5.1 Industry Analysis - Porter’s
3.5.1.1 Bargaining Power Of Suppliers -Moderate
3.5.1.2 Bargaining Power Of The Buyers - Low
3.5.1.3 Threat Of Substitution - Low
3.5.1.4 Threats Of New Entrants -Moderate
3.5.1.5 Competitive Rivalry - High
3.5.2 Pestel Analysis
3.5.2.1 Political And Legal Landscape
3.5.2.2 Economic And Social Landscape
3.5.2.3 Technology Landscape
3.6 Impact Of The Covid-19 Pandemic On Ai In Cancer Diagnostics Market
Chapter 4 Global Artificial Intelligence (Ai) In Diagnostics Market: Competitive Analysis
4.1 Company/Competition Categorization (Key Innovators, Market Leaders, & Emerging Players)
4.2 Recent Developments, By Key Market Participants
4.3 Company Market Position Analysis
Chapter 5 Artificial Intelligence (Ai) In Cancer Diagnostics Market: Component Estimates & Trend Analysis
5.1 Segment Dashboard
5.2 Artificial Intelligence (Ai) In Cancer Diagnostics Market: Component Analysis, 2022 & 2030 (USD Million)
5.3 Ai In Cancer Diagnostics Market, By Component, 2017 - 2030 (USD Million)
5.4 Software Solutions
5.4.1 Software Solutions Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.5 Hardware
5.5.1 Hardware Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.6 Services
5.6.1 Services Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 6 Artificial Intelligence (AI) In Cancer Diagnostics Market: Cancer Type Estimates & Trend Analysis
6.1 Segment Dashboard
6.2 Artificial Intelligence (AI) In Cancer Diagnostics Market: Cancer Type Analysis, USD Million, 2022 & 2030
6.3 AI In Cancer Diagnostics Market, By Cancer Type, 2017 - 2030 (USD Million)
6.4 Breast Cancer
6.4.1 Breast Cancer Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.5 Lung Cancer
6.5.1 Lung Cancer Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.6 Prostate Cancer
6.6.1 Prostate Cancer Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.7 Colorectal Cancer
6.7.1 Colorectal Cancer Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.8 Brain Tumor
6.8.1 Brain Tumor Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.9 Others
6.9.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 7 Artificial Intelligence (Ai) In Cancer Diagnostics Market: End-User Estimates & Trend Analysis
7.1 Segment Dashboard
7.2 Artificial Intelligence (Ai) In Cancer Diagnostics Market: End-User Analysis, USD Million, 2022 & 2030
7.3 Ai In Cancer Diagnostics Market, By End-User, 2017 - 2030 (USD Million)
7.4 Hospitals
7.4.1 Hospitals Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.5 Surgical Centers And Medical Institutes
7.5.1 Surgical Centers And Medical Institutes Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.6 Others
7.6.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 8 Artificial Intelligence (Ai) In Cancer Diagnostics Market: Regional Estimates & Trend Analysis: By Component, Cancer Type, And End-User
8.1 Regional Market Key Takeaways
8.2 Regional Market Snapshot
8.3 Growing Global Cancer Prevalence
8.4 North America
8.4.1 North America Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.4.2 U.S.
8.4.2.1 U.S. Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.4.3 Canada
8.4.3.1 Canada Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.5 Europe
8.5.1 Europe Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.5.2 Uk
8.5.2.1 Uk Ai In Cancer Diagnostics Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.5.3 Germany
8.5.3.1 Germany Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.5.4 France
8.5.4.1 France Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.5.5 Italy
8.5.5.1 Italy Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.5.6 Spain
8.5.6.1 Spain Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.5.7 Russia
8.5.7.1 Russia Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.6 Asia Pacific
8.6.1 Asia Pacific Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.6.2 China
8.6.2.1 China Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.6.3 India
8.6.3.1 India Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.6.4 Japan
8.6.4.1 Japan Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.6.5 South Korea
8.6.5.1 South Korea Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.6.6 Australia
8.6.6.1 Australia Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.6.7 Singapore
8.6.7.1 Singapore AI IN Cancer Diagnostics MARKET Estimates And Forecasts, 2017 - 2030 (USD MILLION)
8.7 Latin America
8.7.1 Latin America Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil Ai In Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.7.3 Mexico
8.7.3.1 Mexico Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.7.4 Argentina
8.7.4.1 Argentina Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.8 MEA
8.8.1 MEA Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.8.2 South Africa
8.8.2.1 South Africa Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.8.3 Saudi Arabia
8.8.3.1 Saudi Arabia Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
8.8.4 UAE
8.8.4.1 UAE Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Competition Categorization
9.3. Company Market Position Analysis
Chapter 10. Company Profiles
10.1.1 EarlySign
10.1.1.1 Overview
10.1.1.2 Financial Performance
10.1.1.3 Technology Benchmarking
10.1.1.4 Strategic Initiatives
10.1.2 Cancer Center.ai
10.1.2.1 Overview
10.1.2.2 Financial Performance
10.1.2.3 Technology Benchmarking
10.1.2.4 Strategic Initiatives
10.1.3 Microsoft
10.1.3.1 Overview
10.1.3.2 Financial Performance
10.1.3.3 Technology Benchmarking
10.1.3.4 Strategic Initiatives
10.1.4 Flatiron
10.1.4.1 Overview
10.1.4.2 Financial Performance
10.1.4.3 Technology Benchmarking
10.1.4.4 Strategic Initiatives
10.1.5 Path AI
10.1.5.1 Overview
10.1.5.2 Financial Performance
10.1.5.3 Technology Benchmarking
10.1.5.4 Strategic Initiatives
10.1.6 Therapixel
10.1.6.1 Overview
10.1.6.2 Financial Performance
10.1.6.3 Technology Benchmarking
10.1.6.4 Strategic Initiatives
10.1.7 Tempus
10.1.7.1 Overview
10.1.7.2 Financial Performance
10.1.7.3 Technology Benchmarking
10.1.7.4 Strategic Initiatives
10.1.8 Paige AI Inc.
10.1.8.1 Overview
10.1.8.2 Financial Performance
10.1.8.3 Technology Benchmarking
10.1.8.4 Strategic Initiatives
10.1.9 Kheiron Medical Technologies Limited Overview
10.1.9.1 Financial Performance
10.1.9.2 Technology Benchmarking
10.1.9.3 Strategic Initiatives
10.1.10 SkinVision
10.1.10.1 Overview
10.1.10.2 Financial Performance
10.1.10.3 Technology Benchmarking
10.1.10.4 Strategic Initiatives
List of Tables
TABLE 1 Global cancer incidence, 2020
TABLE 2 Number of new cases of cancer, by country
TABLE 3 U.S. macro dynamics
TABLE 4 Canada macro dynamics
TABLE 5 Number of new cases of cancer, by country
TABLE 6 UK macro dynamics
TABLE 7 Germany macro dynamics
TABLE 8 France macro dynamics
TABLE 9 Italy macro dynamics
TABLE 10 Spain macro dynamics
TABLE 11 Russia macro dynamics
TABLE 12 Number of new cases of cancer, by country
TABLE 13 China macro dynamics
TABLE 14 India macro dynamics
TABLE 15 Japan macro dynamics
TABLE 16 South Korea Macro dynamics
TABLE 17 Australia macro dynamics
TABLE 18 Singapore macro dynamics
TABLE 19 Number of new cases of cancer, by country
TABLE 20 Brazil macro dynamics
TABLE 21 Mexico macro dynamics
TABLE 22 Argentina macro dynamics
TABLE 23 Number of new cases of cancer, by country
TABLE 24 South Africa macro dynamics
TABLE 25 Saudi Arabia macro dynamics
TABLE 26 UAE macro dynamics
TABLE 27 Key companies undergoing expansions
TABLE 28 Key companies undertaking acquisitions and mergers
TABLE 29 Key companies launching new products/services
TABLE 30 Key companies undertaking collaboration and partnership
TABLE 31 Key companies undertaking other strategies
List of Figures
FIG. 1 Artificial Intelligence (AI) in cancer diagnostics market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 AI in Cancer Diagnostics Market: Research methodology
FIG. 6 Artificial intelligence (AI) in cancer diagnostics market snapshot, (USD Million)
FIG. 7 Artificial intelligence (AI) in cancer diagnostics segment snapshot, (USD Million)
FIG. 8 Artificial intelligence (AI) in cancer diagnostics competitive snapshot, (USD Million)
FIG. 9 Artificial Intelligence (AI) in cancer diagnostics market trends & outlook
FIG. 10 Penetration & growth prospect mapping
FIG. 11 Market driver analysis (Current & future impact)
FIG. 12 Market restraint analysis (Current & future impact)
FIG. 13 Industry analysis- Porter’s
FIG. 14 List of key emerging companies/technology disruptors/innovators
FIG. 15 Company market position analysis
FIG. 16 Artificial Intelligence (AI) in cancer diagnostics market, component outlook key takeaways (USD Million)
FIG. 17 Artificial intelligence (AI) in cancer diagnostics market: Component movement analysis (USD Million), 2022 & 2030
FIG. 18 Software solutions market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 19 Hardware market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 20 Services market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 21 Artificial intelligence (AI) in cancer diagnostics market, cancer type outlook key takeaways (USD Million)
FIG. 22 Artificial intelligence (AI) in cancer diagnostics market: Cancer type movement analysis (USD Million), 2022 & 2030
FIG. 23 Breast cancer market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 24 Lung cancer market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 25 Prostate cancer market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 26 Colorectal cancer market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 27 Brain tumor market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 28 Others market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 29 Artificial intelligence (AI) in cancer diagnostics market, end-user outlook key takeaways (USD Million)
FIG. 30 Artificial intelligence (AI) in cancer diagnostics market: End-user movement analysis (USD Million), 2022 & 2030
FIG. 31 Hospitals market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 32 Surgical centers and medical institutes market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 33 Others market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 34 Regional marketplace: Key takeaways
FIG. 35 Regional market snapshot
FIG. 36 Regional market snapshot
FIG. 37 North America: SWOT analysis
FIG. 38 North America AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 39 Estimated number of new cancer cases, U.S., 2021
FIG. 40 U.S. AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD MILLION)
FIG. 41 Canada AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 42 Europe: SWOT Analysis
FIG. 43 Europe AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 44 UK AI in cancer diagnostics market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 45 Germany AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million )
FIG. 46 France AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 47 Italy AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 48 Spain AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 49 Russia AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 50 Asia Pacific: SWOT analysis
FIG. 51 Asia Pacific AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 52 China AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 53 India AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 54 Japan AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 55 South Korea AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 56 Singapore AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 57 Australia AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 58 Latin America: SWOT analysis
FIG. 59 Latin America AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 60 Brazil AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 61 Mexico AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 62 Argentina AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 63 MEA: SWOT Analysis
FIG. 64 MEA AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 65 South Africa AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 66 Saudi Arabia AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 67 UAE AI in cancer diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)

Companies Mentioned

  • EarlySign
  • Cancer Center.ai
  • Microsoft
  • Flatiron
  • Path AI
  • Therapixel
  • Tempus
  • Paige AI Inc.
  • Kheiron Medical Technologies Limited Overview
  • SkinVision

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages90
PublishedJuly 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 137.8 million
Forecasted Market Value ( USD ) by 2030 $ 996.1 million
Compound Annual Growth Rate26.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

AI In Oncology Market Size, Share & Trends Analysis Report By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

AI In Oncology Market Size, Share & Trends Analysis Report By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Assay Kits And Reagents), By Test (Blood Test, Imaging Test), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Assay Kits And Reagents), By Test (Blood Test, Imaging Test), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
AI in Cancer Diagnostics Market by Component, Deployment, Cancer Type, End-user - Global Forecast 2025-2030 - Product Image

AI in Cancer Diagnostics Market by Component, Deployment, Cancer Type, End-user - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Cancer Diagnostics Market by Diagnostic Type, Indication, Components, End-Use - Global Forecast 2025-2030 - Product Image

Cancer Diagnostics Market by Diagnostic Type, Indication, Components, End-Use - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Gastric Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Gastric Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.